Suppr超能文献

超越同位素标记:拓展蛋白质检测核磁共振在先导化合物发现中的应用范围

Beyond Isotopic Labeling: Expanding the Reach of Protein-Detect NMR in Lead Discovery.

作者信息

Frederick Thomas E, Namanja Andrew T, Wu Haihong, Sun Chaohong, Petros Andrew M

机构信息

Research & Development, AbbVie, 1 North Waukegan Road, North Chicago, Illinois 60064, United States.

出版信息

ACS Med Chem Lett. 2025 Mar 10;16(4):688-692. doi: 10.1021/acsmedchemlett.4c00540. eCollection 2025 Apr 10.

Abstract

Biophysical confirmation of the binding of small molecules to protein targets plays a critical role in lead discovery campaigns. While protein-detect NMR can provide binding confirmation over a range of affinities, it is especially useful, as opposed to other biophysical methods, for ligands which bind weakly to their protein targets, as is often the case early in the lead discovery process. However, the NMR approach, in its most robust form, requires the isotopic labeling of the protein, thus limiting its overall utility. Here we describe an approach to both confirm small-molecule binding and measure ligand affinities that does not require isotopic labeling of protein targets. This novel method utilizes 1D-diffusion filtered NMR followed by ECHOS analysis and will enable the use of protein-detect NMR to characterize ligand-protein interactions for many protein targets which are currently out of reach.

摘要

小分子与蛋白质靶点结合的生物物理确认在先导化合物发现活动中起着关键作用。虽然蛋白质检测核磁共振(NMR)可以在一系列亲和力范围内提供结合确认,但与其他生物物理方法相比,它对于那些与蛋白质靶点弱结合的配体特别有用,而这在先导化合物发现过程的早期经常出现。然而,最强大形式的NMR方法需要对蛋白质进行同位素标记,从而限制了其整体实用性。在这里,我们描述了一种既可以确认小分子结合又可以测量配体亲和力的方法,该方法不需要对蛋白质靶点进行同位素标记。这种新方法利用一维扩散滤波NMR,然后进行ECHOS分析,将能够使用蛋白质检测NMR来表征许多目前无法实现的蛋白质靶点的配体-蛋白质相互作用。

相似文献

1
Beyond Isotopic Labeling: Expanding the Reach of Protein-Detect NMR in Lead Discovery.
ACS Med Chem Lett. 2025 Mar 10;16(4):688-692. doi: 10.1021/acsmedchemlett.4c00540. eCollection 2025 Apr 10.
2
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children.
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011196. doi: 10.1002/14651858.CD011196.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Incentives for preventing smoking in children and adolescents.
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

本文引用的文献

1
Efficiently driving protein-based fragment screening and lead discovery using two-dimensional NMR.
J Biomol NMR. 2023 Apr;77(1-2):39-53. doi: 10.1007/s10858-022-00410-3. Epub 2022 Dec 13.
2
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.
J Med Chem. 2021 Jan 14;64(1):417-429. doi: 10.1021/acs.jmedchem.0c01280. Epub 2020 Dec 30.
3
NMR-based fragment screening and lead discovery accelerated by principal component analysis.
J Biomol NMR. 2019 Dec;73(12):675-685. doi: 10.1007/s10858-019-00279-9. Epub 2019 Sep 20.
5
Spin Diffusion Editing for Structural Fingerprints of Therapeutic Antibodies.
Anal Chem. 2016 Jan 19;88(2):1320-7. doi: 10.1021/acs.analchem.5b03777. Epub 2015 Dec 22.
6
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
Curr Top Med Chem. 2015;15(20):2032-42. doi: 10.2174/1568026615666150519102459.
7
NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.
Chem Rev. 2014 May 14;114(9):4749-63. doi: 10.1021/cr500043b. Epub 2014 Apr 8.
8
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
Bioorg Med Chem Lett. 2014 Mar 15;24(6):1484-8. doi: 10.1016/j.bmcl.2014.02.010. Epub 2014 Feb 14.
9
10
Stereospecific gating of functional motions in Pin1.
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12289-94. doi: 10.1073/pnas.1019382108. Epub 2011 Jul 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验